NCT07745088

Brief Summary

AtlasPROfilax®is a method performed in 2 authorized centers in Colombia focused on patients with chronic non-malignant pain. The study seeks to see the effectiveness of the method in different pathologies through a randomized double-blind study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2025

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

August 4, 2026

Completed
Last Updated

August 4, 2026

Status Verified

January 1, 2026

Enrollment Period

2.4 years

First QC Date

May 6, 2025

Last Update Submit

July 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain reduction

    Description: The patient is asked to rate their pain on a scale of 1 to 10. Scoring: 0: No pain. 1-3: Mild or slight pain. 4-6: Moderate pain. 7-10: Severe pain, the worst pain imaginable. Measurement will be taken on day 1, at 1 month, at 3 months, at 6 months, and at 12 months after the start of the intervention.

    Baseline day 1, post treatment at 1 month post treatment , at 3 months post treatment , at 6 months post treatment, and at 12 months after the start of the intervention.

Secondary Outcomes (1)

  • fatigue severity scale

    Baseline day 1, post treatment at 1 month post treatment , at 3 months post treatment , at 6 months post treatment, and at 12 months after the start of the intervention

Study Arms (2)

Atlasprofilax

EXPERIMENTAL

Participants receive the Atlasprofilax therapy, performed using a certified mechanical device that delivers digitally controlled vibropressure stimulation to the suboccipital region, administered by trained personnel.

Procedure: Atlasprofilax Therapy

Sham Procedure

PLACEBO COMPARATOR

Participants receive a sham procedure that mimics the Atlasprofilax intervention without delivering active vibropressure stimulation or therapeutic effect.

Other: Placebo

Interventions

PlaceboOTHER

The Sham Atlasprofilax Procedure is a non-therapeutic simulated procedure used as a placebo control. Participants undergo the same preparation, positioning, duration, and clinical setting as the experimental Atlasprofilax Therapy. The same device is applied to the suboccipital region; however, the device is deactivated or set to deliver no effective vibro-pressure, therapeutic frequency, or mechanical stimulation. This procedure is designed to have no neuromuscular or therapeutic effect and is used solely to maintain participant and assessor blindin

Also known as: Routine Management
Sham Procedure

Atlasprofilax Therapy is a non-invasive neuromuscular procedure consisting of a single-session application of controlled vibro-pressure to specific points of the suboccipital region. The intervention is performed using a certified mechanical device that delivers digitally controlled percussive vibro-pressure at a predefined frequency and angle, without any manual manipulation of cervical vertebrae. The procedure aims to modulate neuromuscular and fascial tone in the cranio-cervical junction.

Atlasprofilax

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over the age of 18
  • patient who consult the authorized Atlas care center
  • patients with chronic non-malignant pain.

You may not qualify if:

  • Inability to perform physical therapies.
  • patient with pain neuropatict indiferent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bogota

Bogotá, Colombia

Location

Related Publications (5)

  • Calvo-Lobo C, Unda-Solano F, Lopez-Lopez D, Sanz-Corbalan I, Romero-Morales C, Palomo-Lopez P, Seco-Calvo J, Rodriguez-Sanz D. Is pharmacologic treatment better than neural mobilization for cervicobrachial pain? A randomized clinical trial. Int J Med Sci. 2018 Mar 8;15(5):456-465. doi: 10.7150/ijms.23525. eCollection 2018.

    PMID: 29559834BACKGROUND
  • Hallgren RC, Greenman PE, Rechtien JJ. Atrophy of suboccipital muscles in patients with chronic pain: a pilot study. J Am Osteopath Assoc. 1994 Dec;94(12):1032-8.

    PMID: 7852102BACKGROUND
  • McPartland JM, Brodeur RR, Hallgren RC. Chronic neck pain, standing balance, and suboccipital muscle atrophy--a pilot study. J Manipulative Physiol Ther. 1997 Jan;20(1):24-9.

    PMID: 9004119BACKGROUND
  • Basson CA, Stewart A, Mudzi W. The effect of neural mobilisation on cervico-brachial pain: design of a randomised controlled trial. BMC Musculoskelet Disord. 2014 Dec 10;15:419. doi: 10.1186/1471-2474-15-419.

    PMID: 25492697BACKGROUND
  • Charras G, Yap AS. Tensile Forces and Mechanotransduction at Cell-Cell Junctions. Curr Biol. 2018 Apr 23;28(8):R445-R457. doi: 10.1016/j.cub.2018.02.003.

    PMID: 29689229BACKGROUND

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hector Fabio Restrepo-Guerrero

    FNS

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2025

First Posted

August 4, 2026

Study Start

January 1, 2022

Primary Completion

June 1, 2024

Study Completion

June 1, 2025

Last Updated

August 4, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations